Valuation: CSPC Innovation Pharmaceutical Co., Ltd.

Market Cap 48.25B 7.23B 6.48B 5.92B 5.41B 10.19B 679B 10.51B 71.39B 28.47B 362B 27.12B 26.54B 1,144B P/E 2026 *
37.9x
P/E 2027 * 61.7x
Enterprise Value 46.84B 7.01B 6.29B 5.75B 5.25B 9.89B 659B 10.2B 69.3B 27.63B 352B 26.33B 25.76B 1,111B EV / Sales 2026 *
9.35x
EV / Sales 2027 * 9.27x
Free-Float
24.55%
Yield 2026 *
0.9%
Yield 2027 * 1.09%
1 day-3.32%
1 week+7.11%
Current month+7.11%
1 month-26.57%
3 months-15.86%
6 months+7.88%
Current year-3.94%
1 week 29.33
Extreme 29.33
37.24
1 month 29.33
Extreme 29.33
48.9
Current year 22.5
Extreme 22.5
51.78
1 year 22.5
Extreme 22.5
51.78
3 years 19.69
Extreme 19.691665
63.31
5 years 5.41
Extreme 5.412035
63.31
10 years 4.98
Extreme 4.978968
63.31
Manager TitleAgeSince
Chief Executive Officer 49 2024-04-21
Director of Finance/CFO 34 2023-04-06
Corporate Secretary 71 -
Director TitleAgeSince
Director/Board Member 52 2015-12-31
Chairman 50 2015-12-31
Director/Board Member 46 2020-09-06
Date Insider Type Main position Quantity % Market Cap. Importance
4/4/23 Sell

Director

2,700 0.0005%
9/6/22 Buy

Director

10,900 0.0020%
Change 5-day change 1-year change 3-year change Capi.($)
-3.32%+7.11%+10.32%+39.25% 7.23B
-1.58%+1.36%+8.51%-13.82% 269B
-1.20%+1.66%+15.46%-3.61% 83.57B
-2.10%+2.44%-14.17%+18.07% 48.14B
-0.78%-0.68%+25.98%+557.35% 44.99B
+0.37%+7.53%+4.38%-5.02% 35.79B
-0.71%-9.02%+22.80%-2.97% 33.3B
+0.36%+2.64%-5.77%-6.09% 30.69B
+1.29%+4.31%+15.24%+13.95% 29.79B
-2.80%+1.11%+1.36%-25.63% 29.13B
Average -1.05%+2.05%+8.41%+57.15% 61.2B
Weighted average by Cap. -1.19%+1.47%+8.79%+34.97%

Financials

2026 *2027 *
Net sales 5.01B 750M 673M 615M 561M 1.06B 70.49B 1.09B 7.41B 2.95B 37.61B 2.81B 2.75B 119B 4.92B 736M 660M 603M 551M 1.04B 69.19B 1.07B 7.27B 2.9B 36.92B 2.76B 2.7B 117B
Net income 1.4B 210M 188M 172M 157M 296M 19.71B 305M 2.07B 826M 10.52B 787M 770M 33.2B 925M 138M 124M 114M 104M 195M 13.02B 201M 1.37B 546M 6.95B 520M 509M 21.93B
Net Debt -1.41B -211M -189M -173M -158M -297M -19.83B -307M -2.08B -831M -10.58B -792M -775M -33.4B -2.69B -403M -362M -331M -302M -569M -37.92B -587M -3.99B -1.59B -20.23B -1.51B -1.48B -63.88B
Projected Income Statement - Annual - CSPC Innovation Pharmaceutical Co., Ltd.
Logo CSPC Innovation Pharmaceutical Co., Ltd.
CSPC Innovation Pharmaceutical Co Ltd is a China-based company mainly engaged in the research and development, production and sales of functional ingredients. The Company operates two segments. Functional Ingredients segment mainly provides caffeine, acarbose, anhydrous glucose, theophylline, aminophylline, theophylline, theobromine, pentoxifylline, doxofylline, and biological enzymes. Health Food Products segment mainly provides Guoweikang Vitamin C tablets, Guoweikang B vitamin lozenges, and others. The Company mainly conducts businesses within the domestic market.
Employees
2,369
Date Price Change Volume
26-11-06 CN¥34.65 -3.32% 13,454,377
26-11-05 CN¥35.84 +3.70% 22,065,967
26-11-04 CN¥34.56 +16.25% 24,253,538
26-11-03 CN¥29.73 -6.83% 16,661,309
26-11-02 CN¥31.91 -1.36% 17,210,051
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - CSPC Innovation Pharmaceutical Co., Ltd.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
34.65CNY
Average target price
57.13CNY
Spread / Average Target
+64.89%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - CSPC Innovation Pharmaceutical Co., Ltd.
  1. Stock Market
  2. Stocks
  3. 300765 Stock